5SF-20205-20722
2 vaccinations
5 coded responses
9 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 105 / NY
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Moderna
- 2021-03-22
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Slight soreness at injection site but no real painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-29
-
2021-04-19
Dose 2 — Moderna
-
2021-04-19
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Hallucination, Thinking abnormal — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Hallucinating, dizziness, irrational behaviorMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Depression — Feeling: Fair · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesFree text: DepressionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-03
-
2022-04-19
Survey response — 12 months, dose 2MedDRA: Dizziness, Fatigue, Gastrointestinal disorder, Memory impairment, Pyrexia — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Fatigue, dizziness, forgetfulness, GI symptoms, feverMedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Moderna | |
| 2 | 2021-04-19 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-19 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Slight soreness at injection site but no real pain
Release 7 — day 0, dose 2
Systemic reaction (other): Dizziness
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Hallucinating, dizziness, irrational behavior
Systemic reaction (other): Depression
Release 11 — 12 months, dose 2
Symptoms: Fatigue, dizziness, forgetfulness, GI symptoms, fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Depression | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hallucination | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Thinking abnormal | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release